PATTERNS OF NEURONAL DEGENERATION IN THE MOTOR CORTEX OF AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS

被引:189
作者
NIHEI, K
MCKEE, AC
KOWALL, NW
机构
[1] MASSACHUSETTS GEN HOSP,NEUROL SERV,BOSTON,MA 02114
[2] MASSACHUSETTS GEN HOSP,DEPT NEUROPATHOL,BOSTON,MA 02114
[3] YAMAGATA UNIV,DEPT INTERNAL MED 3,YAMAGATA 99023,JAPAN
[4] BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118
[5] BOSTON UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02118
[6] BEDFORD VA MED CTR,CTR GERIATR RES EDUC CLIN,BEDFORD,MA 01730
关键词
AMYOTROPHIC LATERAL SCLEROSIS; MOTOR CORTEX; CYTOSKELETAL PROTEINS; PARVALBUMIN; NADPH-DIAPHORASE;
D O I
10.1007/BF00454899
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis (ALS) patients using traditional cell stains and several histochemical markers including neurofilament, parvalbumin, NADPH-diaphorase, ubiquitin. Alz-50 and tau. Three grades of ALS (mild, moderate, severe) were defined based on the extent of Betz cell depletion. Non-phosphorylated neurofilament immunoreactive cortical pyramidal neurons and non-pyramidal parvalbumin local circuit neurons were significantly depleted in all grades of ALS. In contrast, NADPH-diaphorase neurons and Alz-50-positive neurons were quantitatively preserved despite reduced NADPH-diaphorase cellular staining and dendritic pruning. The density of ubiquitin-positive structures in the middle and deep layers of the motor cortex was increased in all cases. Axonal tau immunoreactivity was not altered. These histochemical results suggest that cortical degeneration in ALS is distinctive from other neurodegenerative diseases affecting cerebral cortex. Unlike Huntington's disease, both pyramidal and local cortical neurons are affected in ALS; unlike Alzheimer's disease, alteration of the neuronal cytoskeleton is not prominent. The unique pattern of neuronal degeneration found in ALS motor cortex is consistent with non-N-methyl-D-aspartate glutamate receptor-mediated cytotoxicity.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 64 条
[1]   LOSS OF PARVALBUMIN-IMMUNOREACTIVE NEURONS FROM CORTEX IN ALZHEIMER-TYPE DEMENTIA [J].
ARAI, H ;
EMSON, PC ;
MOUNTJOY, CQ ;
CARASSCO, LH ;
HEIZMANN, CW .
BRAIN RESEARCH, 1987, 418 (01) :164-169
[2]   DEFINED NEUROFILAMENT, TAU-AMYLOID AND BETA-AMYLOID PRECURSOR PROTEIN EPITOPES DISTINGUISH ALZHEIMER FROM NON-ALZHEIMER SENILE PLAQUES [J].
ARAI, H ;
LEE, VMY ;
OTVOS, L ;
GREENBERG, BD ;
LOWERY, DE ;
SHARMA, SK ;
SCHMIDT, ML ;
TROJANOWSKI, JQ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (06) :2249-2253
[3]  
BEAL MF, 1991, J NEUROSCI, V11, P147
[4]   PARVALBUMIN IN HUMAN-BRAIN [J].
BERCHTOLD, MW ;
CELIO, MR ;
HEIZMANN, CW .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (01) :235-239
[5]   CENTRAL NERVOUS SYSTEM IN MOTOR NEURONE DISEASE [J].
BROWNELL, B ;
OPPENHEIMER, DR ;
HUGHES, JT .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1970, 33 (03) :338-+
[6]   MONOCLONAL-ANTIBODY TO NEUROFILAMENT PROTEIN (SMI-32) LABELS A SUBPOPULATION OF PYRAMIDAL NEURONS IN THE HUMAN AND MONKEY NEOCORTEX [J].
CAMPBELL, MJ ;
MORRISON, JH .
JOURNAL OF COMPARATIVE NEUROLOGY, 1989, 282 (02) :191-205
[7]  
CAMPBELL S K, 1987, Society for Neuroscience Abstracts, V13, P678
[8]  
CARPENTER S, 1968, NERUOLOGY, V18, P741
[9]   COMPARATIVE TOXICITIES OF ALPHA-N-OXALYL-L-ALPHA,BETA-DIAMINOPROPIONIC AND BETA-N-OXALYL-L-ALPHA,BETA-DIAMINOPROPIONIC ACIDS TO RAT SPINAL-CORD [J].
CHASE, RA ;
PEARSON, S ;
NUNN, PB ;
LANTOS, PL .
NEUROSCIENCE LETTERS, 1985, 55 (01) :89-94
[10]  
CHOU SM, 1991, 11TH P INT C NEUR J, P595